Literature DB >> 8174520

Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture.

A W Wamil1, M J McLean.   

Abstract

The investigational anticonvulsant drug, gabapentin (GP; 1-(aminomethyl) cyclohexaneacetic acid) limited repetitive firing of sodium-dependent action potentials of mouse spinal cord and neocortical neurons in monolayer dissociated cell culture. The effect developed slowly over time with sustained exposure. The IC50 was 1.3 x 10(-4) M for exposure times < or = 60 s, 1.9 x 10(-5) M for 10-60 min, and 4.0 x 10(-6) M for 12-48 h. Hyperpolarization restored sustained firing in the continuing presence of GP. Blockade of action potential firing by GP was frequency (use)-dependent. After preincubation with 2.9 x 10(-5) M GP (5 micrograms/ml), trains of brief stimuli at > or = 50 Hz elicited fewer action potentials than in control solution. Also, at 150 Hz, maximal rate of rise of action potentials decreased progressively with repetitive firing in GP-containing, but not control, solution. After overnight incubation in 2.9 x 10(-5) M GP, the absolute refractory period was prolonged from 2.4 +/- 0.6 ms in control solution (n = 11) to 4.7 +/- 0.3 ms (n = 10; P = 0.02 vs. control), and complete recovery from inactivation was prolonged from 8.0 +/- 1.3 ms to 17.0 +/- 2.6 ms (P < 0.001 vs. control). These findings suggest that GP may alter function of voltage-activated sodium channels, but the mechanism is unproven and may be indirect. Limitation of firing was observed in > or = 50% of neurons at concentrations in the range of those found in plasma and cerebrospinal fluid of patients treated successfully with GP. These results suggest that limiting the rate of firing of sodium-dependent action potentials may contribute to the anticonvulsant efficacy of gabapentin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174520     DOI: 10.1016/0920-1211(94)90074-4

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

1.  Down-regulation of N-type voltage-activated Ca2+ channels by gabapentin.

Authors:  Alfonso Vega-Hernández; Ricardo Felix
Journal:  Cell Mol Neurobiol       Date:  2002-04       Impact factor: 5.046

2.  Calcium channel α2δ1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis.

Authors:  Kang-Wu Li; Yanhui Peter Yu; Chunyi Zhou; Doo-Sik Kim; Bin Lin; Kelli Sharp; Oswald Steward; Z David Luo
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

3.  An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons.

Authors:  P Calabresi; D Centonze; G A Marfia; A Pisani; G Bernardi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 4.  Adverse reactions to new anticonvulsant drugs.

Authors:  I C Wong; S D Lhatoo
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

5.  Electrophysiological actions of felbamate on rat striatal neurones.

Authors:  A Pisani; A Stefani; A Siniscalchi; N B Mercuri; G Bernardi; P Calabresi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

Review 6.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 7.  Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Authors:  P N Patsalos; J W Sander
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

8.  A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats.

Authors:  David McClelland; Rhian M Evans; Louise Barkworth; Duncan J Martin; Roderick H Scott
Journal:  BMC Pharmacol       Date:  2004-08-04

Review 9.  Gabapentin in acute postoperative pain management.

Authors:  Connie Y Chang; Chaitanya K Challa; Janki Shah; Jean Daniel Eloy
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

10.  Gabapentin-related suicide: Myth or fact?

Authors:  Ramsis F Ghaly; Ana Plesca; Shalini Rana; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Surg Neurol Int       Date:  2018-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.